Table 2.
Prevalence of Bladder and Bowel Symptoms
| Bladder Symptoms | Survivors % (n) | Controls % (n) | OR (95% CI) | p |
|---|---|---|---|---|
| Storage symptoms | ||||
| Nocturia (2 or more times a night) | 46.2 (48) | 24.0 (25) | 2.7 (1.5 – 4.9) | .001 |
| Urinary urgency | 82.7 (86) | 51.9 (54) | 3.5 (1.7 – 7.2) | .0005 |
| Frequency of daytime urinary leakage: At least once per day | 28.9 (30) | 7.7 (8) | 3.7 (1.5 – 9.2) | .006 |
| Daytime frequency: 9 or more times a day | 14.4 (15) | 16.4 (17) | 0.8 (.3 – 1.9) | .59 |
| Bladder pain | 31.7 (33) | 13.5 (14) | 3.1 (1.4 – 6.6) | .005 |
| Any storage symptom | 96.2 (100) | 83.7 (87) | 3.7 (1.1 – 12.4) | .04 |
| Voiding symptoms | ||||
| Hesitancy | 38.5 (40) | 34.6 (36) | 1.2 (.6 – 2.2) | .64 |
| Straining | 19.2 (20) | 13.5 (14) | 1.3 (.6 – 3.1) | .50 |
| Intermittent stream | 52.9 (55) | 48.1 (50) | 1.1 (.6 – 2.0) | .80 |
| Any voiding symptom | 58.7 (61) | 59.6 (60) | 0.9 (.5 – 1.7) | .78 |
| Incontinence symptoms | ||||
| Urge urinary incontinence | 72.1 (75) | 49.0 (51) | 2.2 (1.2 – 4.2) | .01 |
| Stress urinary incontinence | 73.1 (76) | 50.0 (52) | 2.1 ((1.1 – 4.0) | .02 |
| Mixed urinary incontinence | 64.4 (67) | 32.7 (34) | 2.9 (1.6 – 5.5) | .0008 |
| Enuresis | 40.4 (42) | 9.6 (10) | 5.7 (2.5 – 12.8) | .0001 |
| Nocturnal enuresis | 27.9 (29) | 7.7 (8) | 3.4 (1.3 – 8.6) | .01 |
| Any incontinence symptom | 82.7 (86) | 66.4 (69) | 2.1 (1.0 – 4.3) | .04 |
| Bowel Symptoms* | ||||
| Diarrhea | 29.8 (31) | |||
| Constipation | 36.5 (38) | |||
| Both diarrhea and constipation | 22.2 (14) | |||
| Bloating | 52.9 (55) | |||
| Any bowel symptom | 71.2 (74) | |||
| Pelvic pain* | 35.6 (37) | |||
*
The larger study quality of life study from which the current study is derived did not include administering the MSAS to non-cancer controls; thus data on bowel symptoms and pelvic pain are not available for comparison purposes from non-cancer controls.